Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosis.
Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosis.
复制标题
DOI:
10.1084/jem.20160283
复制
发表时间:
2016-08-22
期刊:
影响因子:
--
通讯作者:
Estrov Z
中科院分区:
文献类型:
--
作者:
Verstovsek S;Manshouri T;Pilling D;Bueso-Ramos CE;Newberry KJ;Prijic S;Knez L;Bozinovic K;Harris DM;Spaeth EL;Post SM;Multani AS;Rampal RK;Ahn J;Levine RL;Creighton CJ;Kantarjian HM;Estrov Z
Estrov and collaborators examine the role of fibrocytes in primary myelofibrosis and propose a novel therapeutic approach. Primary myelofibrosis (PMF) is a fatal neoplastic disease characterized by clonal myeloproliferation and progressive bone marrow (BM) fibrosis thought to be induced by mesenchymal stromal cells stimulated by overproduced growth factors. However, tissue fibrosis in other diseases is associated with monocyte-derived fibrocytes. Therefore, we sought to determine whether fibrocytes play a role in the induction of BM fibrosis in PMF. In this study, we show that BM from patients with PMF harbors an abundance of clonal, neoplastic collagen- and fibronectin-producing fibrocytes. Immunodeficient mice transplanted with myelofibrosis patients’ BM cells developed a lethal myelofibrosis-like phenotype. Treatment of the xenograft mice with the fibrocyte inhibitor serum amyloid P (SAP; pentraxin-2) significantly prolonged survival and slowed the development of BM fibrosis. Collectively, our data suggest that neoplastic fibrocytes contribute to the induction of BM fibrosis in PMF, and inhibiting fibrocyte differentiation with SAP may interfere with this process.